Related Experiment Video
Updated: Jun 22, 2026
12:54
Transient Expression of Proteins by Hydrodynamic Gene Delivery in Mice
Published on: May 5, 2014
IGF-I and GH: potential use in gene doping
Stephen D R Harridge1, Cristiana P Velloso
1Division of Applied Biomedical Research, School of Biomedical and Health Sciences, Shepherd's House, Guy's Campus, King's College London, London SE1 1UL, United Kingdom. s.harridge@kcl.ac.uk
Summary
Gene doping, the misuse of gene therapy for athletic enhancement, involves targeting Insulin-like Growth Factor-I (IGF-I). Animal studies show IGF-I boosts muscle growth and function, but human application faces challenges.
Area of Science:
- Sports Science
- Genetics
- Biotechnology
Background:
- Gene doping involves gene therapy for athletic performance enhancement.
- Insulin-like Growth Factor-I (IGF-I) is a key target for performance improvement.
- Animal studies indicate IGF-I's role in muscle development.
Purpose of the Study:
- To explore the potential of IGF-I gene doping for athletic performance.
- To review animal studies on IGF-I gene transfer and muscle enhancement.
- To identify challenges in translating these findings to human athletes and anti-doping efforts.
Main Methods:
- Review of transgenic and somatic gene transfer studies in animals.
- Analysis of IGF-I upregulation effects on muscle growth and function.
- Examination of detection challenges for anti-doping authorities.
Main Results:
- Upregulation of IGF-I in muscle stimulates growth and improves function in animal models.
- Increased muscle IGF-I does not necessarily lead to higher circulating IGF-I levels.
- Animal study results suggest performance benefits, but human application is technically challenging.
Conclusions:
- Gene doping using IGF-I shows promise in animal models for muscle enhancement.
- Significant technical hurdles exist for human application of IGF-I gene doping.
- Detecting endogenously produced enhanced gene products poses a challenge for anti-doping agencies.
Related Concept Videos
00:49What is Genetic Engineering?
Overview
02:11Reporter Genes
Reporter genes are a type of protein-coding gene that are often tagged to a gene of interest. Once inside a target cell, reporter genes usually produce visually identifiable characteristics like fluorescence and luminescence when expressed along with the gene of interest. Thus, reporter genes “report” the presence or absence of genes of interest in an organism, determine the gene expression pattern, or track the physical location of a DNA segment or protein in the cell.
Commonly used reporter...
Commonly used reporter...
00:59Gene Therapy
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
02:50Transgenic Plants
Recombinant DNA technology called transgenesis is often used to add a foreign gene or remove a detrimental gene from an organism. Such genetically modified organisms are called transgenic organisms.
The first-ever transgenic plant was a tobacco plant developed in 1983 that showed resistance against the tobacco mosaic virus. Since then, many transgenic plants have been developed and commercialized for improving the agricultural, ornamental, and horticultural value of a crop plant. Transgenic...
The first-ever transgenic plant was a tobacco plant developed in 1983 that showed resistance against the tobacco mosaic virus. Since then, many transgenic plants have been developed and commercialized for improving the agricultural, ornamental, and horticultural value of a crop plant. Transgenic...
00:53Transgenic Organisms
Overview
01:16In-vitro Mutagenesis
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.